(RZB) |
| 0 (0%) 04-14 10:46 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 29.39 |
| Resistance 1: | 25.16 |
| Pivot price: | 25.03 |
| Support 1: | 24.95 |
| Support 2: | 24.82 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 6.090 |
| Book Value | 205.630 |
| PEG Ratio | 0.00 |
| Gross Profit | 51.617 |
| Profit Margin (%) | 4.99 |
| Operating Margin (%) | 9.16 |
| Return on Assets (ttm) | 0.9 |
| Return on Equity (ttm) | 9.7 |
Company news
Sun, 12 Apr 2026
How Reinsurance Group Of America Incorporated 5.75% Fixed-to-floating Rate Subordinated Debentures Due 2056 (RZB) Affects Rotational Strategy Timing - Stock Traders Daily
Thu, 20 Nov 2025
RGA Baby Bond RZB - Good Place To Park Cash (NYSE:RZB) - Seeking Alpha
Wed, 01 Oct 2025
Examining the real-world effectiveness and safety of risankizumab in patients with Crohn's disease - Mayo Clinic
Fri, 27 Jun 2025
Live Flight Tracker - Real-Time Flight Tracker Map - Flightradar24
Thu, 15 May 2025
Risankizumab Effective in Difficult-to-Treat Psoriasis Areas - Dermatology Times
Fri, 08 Mar 2024
Live Flight Tracker - Real-Time Flight Tracker Map - Flightradar24
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
